Monday, 27 April 2020

Pediatric Vaccines Market Global Analysis With Focus On Opportunities, Development Strategy, Comprehensive Plans, Competitive Landscape And Trends

Pediatric Vaccines Market Synopsis:
Pediatric vaccinations are extensively in demand for preventing children from getting infectious as well as non-infectious diseases. Market Research Future (MRFR) has assessed in its latest report that the global pediatric vaccine market size is expected to expand at a double-digit CAGR of 10.6% during the projection period 2017 to 2023.

Increasing awareness about diseases and available vaccines has intensified the fueled demand for these vaccines in the past few years. A similar trend is anticipated to be witnessed in the pediatric vaccines market over the next couple of years. In addition, the advancements in the global healthcare sector are also projected to develop the market in the years to come.

Pediatric Vaccines Market Segmentation:
By type, the global pediatric vaccines market has been segmented into multivalent vaccines, monovalent vaccines, and others.
Based on technology, the pediatric vaccines market has been segmented into dendritic cells vaccines, synthetic vaccines, conjugate vaccines, live attenuated vaccines, toxoid vaccines, inactivated and subunit vaccines, recombinant vaccines, and others.
Based on disease indication, the global pediatric vaccines market has been segmented into polio, Haemophilus influenza type B, MMR (Measles, Mumps, and Rubella), pneumococcal disease, influenza, DTP (Diphtheria, Tetanus, Pertussis), meningococcal disease, hepatitis, combination vaccines, varicella, rotavirus, and others.
By route of administration, the pediatric vaccines market has been segmented into subcutaneous administration, intramuscular administration, oral administration, and other routes of administration

Pediatric Vaccines Market Regional Analysis:
By region, the geographical evaluation of the pediatric vaccines market spans across four major regions, viz. Americas, Europe, Asia Pacific, and the Middle East and Africa (MEA). Americas is anticipated to account for the maximum market share of the global market over the next couple of years. The increasing number of awareness campaigns organized by the healthcare service providers, organizations, and the government is expected to boost the revenue generation of the pediatric vaccines market in the region across the forecast period. The U.S. Department of Health and Human Services (HHS) is prognosticated to play a crucial role in the development of the market in the region over the next couple of years.

Europe is also projected to expand at a significant pace in the forthcoming years. The increasing investments by the governments for promoting vaccination is likely to propel the growth of the pediatric vaccines market in the years to come. Asia Pacific is also likely to witness rapid developments. The economic development of the region, in conjunction with advancements in the healthcare sector, is forecasted to catalyze proliferation of the pediatric vaccines market in the foreseeable future. The Middle East & Africa is projected to grow at a steady pace during the assessment period. Healthcare sector in the Middle East has been observing immense developments which are poised to push the market on its growth trajectory.


Pediatric Vaccines Market Competitive Dashboard:
The noted players of the pediatric vaccines market profiled in this MRFR report are GlaxoSmithKline plc (U.K.), Merck & Co., Inc. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur SA (France), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), Astellas Pharma Inc. (Japan), Johnson & Johnson (U.S.), Serum Institute of India Pvt. Ltd. (India), MedImmune, LLC (U.S.), Bavarian Nordic (Denmark), Daiichi Sankyo (Japan), Protein Sciences Corporation (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), Grifols (Spain), Bharat Biotech (India), Kaketsuken (U.S.), Crucell (Netherlands), Panacea Biotec (India), Zydus Cadila (India), Nuron (U.S.), Baxter International (U.S.), S K Chemicals (South Korea), Bharat Immunologicals and Biologicals (India), Dynavax Technologies (U.S.), Lupin Pharmaceuticals, Inc. (India), Novartis AG (Switerzland), LG Life Sciences (India), Indian Immunologicals (India), Shenzhen Kangtai Biological Products (China), Bio Med (India), AstraZeneca (UK), Sinovac Biotech (China), bioCSL Inc. (U.S.), Takeda Pharmaceutical (Japan), and Valeant Pharmaceuticals (U.S.).

Respiratory Inhalers Market Size, Emerging Technologies And Analysis

Respiratory Inhalers Market Analysis
Global Respiratory Inhalers Market is expected to exhibit a strong 6.1% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global respiratory inhalers market is likely to be driven by the growing prevalence of respiratory conditions such as asthma and chronic obstructive pulmonary disorder (COPD), along with the growing demand for technological innovation to make the operation of inhalers smoother and more precise. The growing prevalence of smoking is also likely to be a major driver for the global prevalence of asthma and other respiratory diseases, thus driving the global respiratory inhalers market at a stable growth rate over the forecast period. 

According to the WHO, more than 300 million people are affected by asthma worldwide, with COPD accounting for more than 200 million. The growing prevalence of respiratory conditions such as asthma and COPD is likely to be the prime driver for the global respiratory inhalers market over the forecast period. Rising pollution levels and industrialization in urban areas around the world has been a major factor for the growing prevalence of such diseases. The increasing rate of urbanization in developing countries is likely to further drive the importance of this factor over the forecast period, as the rising number of urban residents will not only lead to a rise in the levels of vehicular pollution, but also lead to a rise in the volume of industrial activities to keep up with the growing economy.
A study conducted in the Ann & Robert H. Lurie Children's Hospital of Chicago in April 2019 found that 42% of the test subjects, who were 113 children from the age of 2 to 16 suffering from asthma, missed a key step in the operation of their inhalers, resulting in inadequate efficacy of the device. Such studies have highlighted the need for direct intervention from doctors and healthcare agencies to educate patients on the correct, most effective utilization of respiratory inhalers.

Respiratory Inhalers Market Competitive Analysis:
Leading players in the Global Respiratory Inhalers Market include
  • Adherium Limited
  • Boehringer Ingelheim GmbH
  • GSK plc
  • Teva Pharmaceutical Industries Ltd.
  • Propeller Health
  • Chiesi Farmaceutici S.p.A.
  • AstraZeneca
Respiratory Inhalers Market Segmentation:
The Global Respiratory Inhalers Market is segmented on the basis of operation, product type, application, end use, and region.

The respiratory Inhalers market has been segmented on the basis of operation into manually operated and digitally operated respiratory inhalers. Manually operated inhalers accounted for a dominant market share of close to 90% in 2016, dwarfing the demand for digitally operated respiratory inhalers primarily due to the higher costs of the latter.
On the basis of product, the respiratory inhalers market is segmented into dry powder inhaler, metered dose inhaler, and others. Dry powder inhalers accounted for the largest market share in 2016.

On the basis of application, the global respiratory inhalers market is segmented into asthma, COPD, and others. Asthma accounted for the largest market share in 2016 and is likely to remain the leading revenue generation channel for the global respiratory inhalers market over the forecast period due to the increasing prevalence of the disease in developed regions.

On the basis of end user, the global respiratory inhalers market is segmented into hospitals and clinics, respiratory care centers, and others. The hospitals and clinics segment dominated the global market in 2016 and is likely to remain the leading end user in the market over the forecast period.


Respiratory Inhalers Market Regional Analysis:
North America is the largest regional market for respiratory inhalers and accounted for more than 35% of the global market in 2016. The North American market for respiratory inhalers is likely to reach a valuation of close to USD 12 billion by 2023, due to the growing prevalence of asthma and COPD in the region. COPD is considered among the leading causes of death in North America and accounted for the third largest number of deaths in the U.S. in 2014.
The strong presence of leading players in Europe is likely to drive the Europe market for respiratory inhalers over the forecast period.

Sunday, 26 April 2020

Fertility Services Market 2020 – Industry Trends And Forecast To 2025

Fertility Services Market Overview
Fertility services are defined as services that can help both men and women to overcome medical problems, which prevent them from having children. A new report on the global fertility services market, published by Market Research Future (MRFR), observes that this market could find growth at 8.50% CAGR between 2018 and 2023.

The prominent market enhancing factors for the global fertility services market share include growing urbanization, rising numbers of women joining the workforce, the inclination of women for advanced studies, delayed family planning, and reimbursement schemes. Another crucial factor contributing to the market growth include advances in fertility treatment that gives women options to bear children in later years. Such technologies are gaining popularity due to use and endorsement by female celebrities. However, high costs for fertility treatments can affect market growth negatively.

Fertility Services Market Segmentation
The global fertility services market segmentation encompasses the underlying cause and treatment type. MRFR’s take on the market explores various facets of the market in-depth.

Based on the underlying cause, this market has been segmented into male infertility and female infertility. The female infertility is expected to hold the larger market share of 54% during the forecast period. Factors attributed to the growth of this market segment include elapsed age of motherhood, endometrial tuberculosis, the prevalence of obesity, and other medical conditions.

By treatment types, the market has been segmented into assistive reproductive technology (ART) and infertility drugs. The ART segment is expected to hold the larger market share of 76% during the forecast period as it is the preferred treatment for infertility due to its high success ratio. The ART segment has been sub-segmented into artificial insemination, frozen embryo replacement (FER), in-vitro fertilization (IVF), and others. Increased demand for IVF is boosting the market growth.

Fertility Services Market Regional Segmentation
A geographical outlining of the global fertility services market covers Europe, The Americas (North America & Latin America), Asia Pacific, and the Middle East & Africa (MEA).

Expected to grow at 8.50% CAGR during the forecast period, Europe holds the largest market share of 34.6% due to the low fertility rate in this region. The trend of delayed family planning is also aiding market growth. The reimbursement policies in the majority of European countries are also promoting the demand for fertility services. Due to the availability of advanced medical facilities and economic development, Western Europe is the bigger market segment, compared to Eastern Europe. The paramount country-specific markets in this region include France, Germany, Italy, Spain, and the UK. An analysis of the remaining countries in Western Europe featured in this report estimates the huge contribution to market revenue from some other countries, along with and a sizable revenue contribution from Eastern Europe.

The Americas region is the second-largest regional market with North America occupying the major chunk of market revenue due to the same reasons as in Europe. North America generates higher market revenue due to the presence of key market players, high obesity rates in the USA, and subsequent dip in fertility rates. Hence, more women are now turning to fertility services, leading the market to grow. After the USA, Canada has the biggest chunk of market revenue. A decent market revenue share also comes from Latin America.

During the forecast period, the Asia Pacific region can grow at the fastest pace due to rapid urbanization in the region, subsequent changing lifestyles, and the emergence of increased fertility problems. Adoption of sophisticated technology and increasingly favorable reimbursement policies can improve the market growth in countries like India and Japan. Other significant country-specific markets in this region are Australia, China, and South Korea. An analysis of the remaining countries in the Asia Pacific region featured in this report anticipates the huge contribution to market revenue from some other countries.

The market growth in the MEA region is low due to lack of awareness, limited availability of skilled medical professionals, various social restrictions due to many religious as well as cultural factors, less investment in the healthcare sector, and dearth in advanced medical facilities.


Fertility Services Market Key Players
Prominent players in the global fertility services market include CARE Fertility Group Limited (UK), Cook Medical (USA), CooperSurgical Inc (USA), Ferring Pharmaceuticals Inc. (USA), Irvine Scientific (USA), Merck KGaA (Germany), and Vitrolife (USA).

Nurse Call System Market Comprehensive Analysis, Business Opportunities, Development Strategy, Emerging Technologies, Global Trends

Nurse Call System Market Outlook
Global nurse call system market is expected to grow significantly over the forecast period. It is estimated that the global nurse call system market share is expected to register a CAGR 9.5 % during the forecast period from 2018 to 2023. Nurse call systems are aimed at alerting the nurses in case of medical emergency situations or when patients need care. These systems are also used to track a patient particularly in assisted living or old age centers or are used to give a signal of a probable situation in case of ambulatory services.

Numerous factors such as growing geriatric population and rising complexity of hospital operations are expected to drive the growth of the market.

Moreover, favorable healthcare investments by government and the rising demand for better technological advancements boosts the growth of the market. However, stringent government regulation and the huge cost of installation may hamper the market growth during the assessment period.

Some of the industry players offer integrated equipment, in which the patient data can easily be stored and retrieved. In February 2015, Rauland Borg Corporation launched a device called AllTouch responder, which offers nurse call system with electronic medical records. The nurse call equipment has evolved over the time owing to better patient monitoring. The staff members can directly communicate with the patients to assist them and provide required care, thereby reducing the need to visit the patient beds for minor requirements. This can eliminate fatigue and increase the workflow efficiency of the attendant.

Nurse Call System Market Competitive Analysis:
Some of the major companies in the global nurse call system market include Honeywell International Inc., Austco Communication Systems Pty Ltd., Hill-Rom Services Inc., Johnson Controls., Ascom, CSINC, STANLEY Healthcare, AMETEK, Inc., West-Com Nurse Call System, Inc, Cornell Communications, Azure Healthcare, Jeron Electronic Systems Inc., BEC Integrated Solutions, LLC, Vigil Health Solutions Inc., and Systems Technologies.

Nurse Call System Market Segmentation:
The nurse call system market is segmented on type, applications, technology, end users, and region.
Based on the type, the market is segregated into nurse call integrated communication systems, nurse call buttons, nurse call intercoms, nurse call mobile systems, and others.

By technology, the market is segmented into wireless systems and wired systems.
Based on the applications, the market is segmented into alarms, medical emergency, workflow management, and others.

Based on the end users, it is segmented into assisted living centers, hospitals & nursing homes, ambulatory care centers, and others. Of these, hospitals and nursing homes segment is anticipated to be the larger shareholder in the overall market share. The growth of the segment is primarily attributable to the rising number of public as well as private hospitals.


Nurse Call System Market Regional Analysis:
Regionally, the nurse call system market is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, the Americas is anticipated to dominate the market for nurse call system due to faster demand for newer technologies and upgradation of nurse call systems in the region. Additionally, the growing geriatric population and increasing funding for better healthcare infrastructure in the region. In addition to this, the Europe is estimated to hold the second leading position in the market owing to well-developed healthcare industry and investment for increasing number of hospitals.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the developing healthcare facilities in the developing economies and increasing aging population. According to a report published by Silver Eco in October 2017, in Japan, 27.7 people are elderly or aged.

Cardiac Pacemaker Market Business Opportunities And Competitive Landscape

Cardiac Pacemaker Market Overview:
Cardiac pacemaker is a device that can manage the heart rhythm artificially. The device sends electric pulse to heart to keep the rhythm normal. Technological progress and curbed costs are major driving factor for the cardiac pacemaker market growth, which is expected to garner 7.9% CAGR during the forecast period (2017-2023). Market research Future (MRFR) makes a claim in their recently published analysis of the global cardiac pacemaker market that the attainment of the valuation mark would be easier for the market during the forecast period.

Several factors like growing geriatric population, better affordability, technologically-advanced devices, growing health-related issues, and others are expected to help the global cardiac pacemaker market make the leap in terms of growth during the forecast period. However, the market growth can be hampered due to the necessity of surgery for the procedure, which a lot of people wish to avoid. Also, the risk of malfunctioning can be a great deterrent for the market.

Cardiac Pacemaker Market Segmentation:
MRFR’s report on the global cardiac pacemaker market has a sound foundation on segments like type, technology, application, and end-users. This segmentation is amply backed by various volume-wise and value-wise data results.
Based on the type, the cardiac pacemaker market can be segmented into external cardiac pacemaker, implantable, and others. the implantable pacemakers are expected to gain substantial market coverage.

Based on the technology, the cardiac pacemaker market can be segmented into single-chambered, biventricular, dual-chambered, and others.

Based on the application, the cardiac pacemaker market can be segmented into congestive heart failure, arrhythmias, and others. The arrhythmias segment covers tachycardia, bradycardia, and others for a better analysis.
By end-users, the cardiac pacemaker market can be segmented into medical institutes, cardiac care centers, hospitals, and others. the hospitals segment is getting traction due to patients showing high preference for this one. Hospitals are better-equipped to tackle various other aspects as well.

Cardiac Pacemaker Market Regional Analysis:
The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions that have been included in the global cardiac pacemaker market report, conducted by MRFR. This report aims at providing a closer look of the market that would help in the identification of various factors.

The Americas is enjoying the dominance it has over the global market and is expected to continue in the coming years as well by providing substantial backups for the sector. The regional market is enjoying the presence of various factors like robust infrastructure, high technological inclusion, better investment capacity, and others. The rise in geriatric population is also expected to build up market expansion possibility. 

Europe holds the second spot and is enjoying similar features like that of the Americas, especially, North America. The regional market has several countries like Germany, France, the UK, and others who are impacting the regional market. The region is also investing much for research and development, which is creating enough scope for market expansion. 

The APAC market has several regions like India, China, Australia, Japan, Korea, Thailand, Singapore, and others who are spending substantial money in taking the regional market ahead. The region is also the fastest growing one that can bank on rising healthcare expenditure, huge patient population, better per capita income, and transforming policies to ease the integration process of the global market can make the market grow faster. 


Cardiac Pacemaker Market Competitive Landscape:
Several companies are promoting the global cardiac pacemaker market substantially to take advantage from the rapidly inflating profits. These companies are launching their own strategies to solidify their market position and their efforts can ensure a holistic growth for the global cardiac pacemaker market. These companies are Abbott. (U.S.), Medtronic (U.S.), BIOTRONIK (Germany), Boston Scientific Corporation (U.S.), SORIN Group (Europe), LEPU MEDICAL (U.K), OSCOR Inc. (U.S.), MEDICO S.p.A. (Europe), and others. MRFR enlisted these companies in the recently published report on the same and had profiled them to get a detailed look into the market.

Foley Catheters Market Latest Innovations, Analysis, Business Opportunities, Component, Industry Revenue And Forecast

Foley Catheters Market Overview
A foley catheter is commonly known as a flexible urinary drainage tube that passes through the urethra and subsequently into the bladder with the aid of a tiny water-inflated balloon. They technology for the same is improving at a continuous pace and is bringing forward new opportunities in the market. These products are usually recommended by healthcare experts and providers for individuals who suffer from bladder-related issues like urinary incontinence and urinary retention. The rising incidence of urologic diseases across the globe is the primary driver pushing the market growth of foley catheters.

The global foley catheters market was analyzed by Market Research Future (MRFR) and it was projected that a decent CAGR of 7.8% will be attained by the market over the forecast period of 2014 to 2023. The valuation of the foley catheters market was further stated to surpass its previous valuation to reach USD 987.3 million by 2023.

Foley Catheters Market Segmentation
The global foley catheters market has been segmented in terms of type, end-user, and material.

By material, the market includes silicone elastomer coated latex, silicone, silicone elastomer coated latex, latex, polytetrafluoroethylene PTFE (Teflon) coated latex, hydrophilic polymer coated latex, and others. The latex segment holds the largest share in the global market of foley catheters. Whereas, the hydrophilic polymer coated latex segment is anticipated to grow during the forecast period at a notable pace of 8.3%.

By type, the market is segmented into 4-way catheters, 3-way catheters, 2-way catheters, and others. The 2-way catheters segment leads the global market with the largest percentage of share to its name. The segment is anticipated to grow at a considerable pace to attain a revenue worth USD 527.4 by 2023.

By end-users, the market divides into medical research center, hospitals, and ambulatory surgery centers.

Foley Catheters Market Regional Analysis
The global foley catheters market is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Rest of the World (RoW).

The North American region is estimated to be the leading contributor for Foley catheters in the coming years. The growth of the regional market can be credited to the large pool of money being invested in research and development activities and increasing product development being made herein. Back in 2016, the market in North America stood at a valuation of USD 228.8 Million and is expected to surpass the same by the end of the ongoing assessment period. The region also includes established healthcare facilities alongside attractive reimbursement policies, which are collectively influencing the growth of the market.

The European region is reported to maintain its second position in the global foley catheters market. This is due to the rising adoption of some of the latest and advanced products as well as technologies in this region. The market is reported to reach a valuation of USD 306.1 million by the end of the forecast period. In Europe, the U.K. is slated to experience the fastest growth percentage, while Germany is expected to dominate the regional market.

The Asia Pacific region holds an important position in the market of foley catheters globally. The regional market is said to experience rapid growth rate in the coming years. The growth of the Asia Pacific market can be attributed to the widespread incidence of various urological diseases and the increasing expenditure in the healthcare sector. Emerging nations like China and India are primed to be higly lucrative areas for the market due to the prevalence of chronic diseases, expanding geriatric population, and accelerating demand for advanced therapies as well as products.


Foley Catheters MarketCompetitive Landscape
The global foley catheters market comprises a host of key players. This includes names like Medline Industries Inc. (US), Cook (US), Teleflex (US), B. Braun Melsungen AG (Germany), Coloplast Ltd (Denmark), and Medtronic (Republic of Ireland).

Medical Writing Market Size, Share, Growth Drivers, Investment Opportunities And Strategies

Medical Writing Market Overview: 
Global medical writing market has evolved exponentially with the expansion of the pharmaceutical and biotechnology industries. The use of medical writing is extensive in pharmaceutical & biotechnology companies. Moreover, the burgeoning CRO industry fosters the growth of the market. With the increase in patent expiration, the need to draft new patents is growing too, which, as a result, drives the medical writing market. Cumulatively led by these factors, the global medical writing market valuation is expected to cross USD 3.25 BN by 2025 at a CAGR of 10.1 % during 2019-2025.

Medical Writing Market Drivers & Restraints 
Medical writing comprises scripting of diverse scientific information, preparing regulatory paperwork, and publication of documents related to drug discovery, clinical trials, and several other written communication work intended for regulatory bodies, health care providers, researchers, the general public, etc.

Medical writing requires medical knowledge and understanding of drug development and regulatory guidelines. It plays a vital role in the success of various clinical trials and research projects. It is quite challenging to handle pre-approval regulatory writing, develop a scientific platform & publication plan, promotional & educational materials, all at once by a single company. Hence, this medical writing has been the preferred model for quite some time now. 

Hiring a medical writing vendor benefits, not just the pharmaceutical companies but also to the patients and society ultimately. Resultantly the global medical writing market has been making quite a stride over the last few years. Increasing demand for regulatory paperwork in the pharmaceutical and biopharmaceutical industry is a significant driving force behind the growth of the market. Besides, rising patent expiration has been leading to increasing the demand for medical writers in recent years.

Substantial investments made in the rising numbers of research and development activities in the pharma & biotechnology industries are directly linked to the growth of the market. As various companies and government bodies are investing in R&D of clinical trials, the demand for clinical writing is increasing. Also, medicines are becoming more complex nowadays, and the pharmaceutical industry is becoming increasingly focused on their core competency of drug discovery.  

Consecutively, pharma companies are getting heavily reliant on outsourced partners for non-core capabilities, such as medical writing. The increased reliance in terms of strong, highly credentialed, and responsive service providers to assist with the publication, regulatory, and promotional strategies offers an exciting opportunity for the medical writing industry. However, factors such as stringent government regulatory policies are restraining the growth of the market. 

Medical Writing Market – Segments
The report has been segmented into four major dynamics.
By Type: Clinical Writing, Scientific Writing, Regulatory Writing, Disease & Drug-Related Writing, and others.
By ApplicationMedical Education, Medical Journalism, Medico Marketing, and others.
By End UserPharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS), and others.
By Regions : Americas, Europe, Asia Pacific, Middle East & Africa, and Rest-of-the-World.


Global Medical Writing Market – Regional Analysis

North America accounts for the largest share in the global medical writing market, attributing to the well-developed healthcare, pharmaceutical, and biotechnology industries. The presence of major players and pharma & biotechnology companies foster the market growth excellently. Moreover, increasing the consumption of medicines, medical devices, and other pharmaceutical products drive the growth of the regional market.
Furthermore, substantial investments made in the discovery and development of various drugs and medical products impact the market growth positively. Also, rising numbers of researches in biotechnology alongside the burgeoning CRO industry substantiate the growth of the regional market. The North American medical writing market is expected to grow at a substantial CAGR over the forecasted period.

Europe is another lucrative market for medical writing. The presence of some of the best healthcare services propels the growth of the regional market. Moreover, the growth of the healthcare industry and the expansion of various biopharmaceutical industries in the region create a massive demand for medical writing. Indeed, the resurging economy in the region is a dominant factor substantiating the market growth, increasing the healthcare and pharmaceutical industries.

The market size is increasing with the augmenting demand for CMOs and CTOs. Also, increasing government funding initiated to increase the numbers of R&D activities for the drug discoveries, provides impetus to the regional market growth. The European medical writing market is expected to grow at a considerable CAGR over the assessment period.

The medical writing market in the Asia Pacific region is emerging as a profitable market. The region has the world’s largest population and fast-developing healthcare industry. The rapidly growing pharma industry, alongside the healthcare industry, fosters the market growth in the region. Besides, the availability of skilled professional and cost-competitive services allows the region to have the edge over other regions. The APAC medical writing market is expected to grow at a rapid rate during the forecasted period. 

Medical Writing Market – Competitive Analysis
Highly competitive, the medical writing market appears to be well-established, with many players forming a competitive landscape. The competitive strength of these players is highly dependent on service precision, service pricing, versatility, and service reliability. Service providers operating in the medical writing market strive to offer quality services that are based on best practices. 


Medical Writing Market Major Players: 
Key players leading the global medical writing market include Freyr Solutions (US), Parexel International Corporation (US), Cactus Communications (UK), IQVIA (US), Covance Inc. (US), OMICS International (India), SIRO CLINPHARM (India), SYNCHROGENIX (US), INCLIN, (US), and Clinexa Life Sciences Pvt (Australia), among others. 

Medical Writing Industry/ Innovation /Related News: 
January 23, 2020 ---- Nuvisan Pharma Services GmbH & Co KG (Germany), a leading global CRO/CDMO, announced the acquisition of Inamed GmbH (Germany), an international Contract Research Organization (CRO). Nuvisan Pharma provides pharmaceutical research services while Inamed is specialized in clinical trials with patients living with respiratory and rare diseases.

Inamed offers a wide range of clinical trial and related services, such as medical writing, project management, and others. Over the last several years, Nuvisan and Inamed have worked together, collaborating on a number of services. The merger is the logical next step in this long-lasting, successful cooperation.

Automatic Pill Dispenser Market 2020: Global Opportunities, Growth Factors And Forecast By Regions, Dynamics, Development Status And Outlook 2024

Market Research Future Published a Half-Cooked Research Report on the Global Automatic Pill Dispenser Market.

Automatic Pill Dispenser Market Highlights
Global Automatic Pill Dispenser Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 1,700 million in 2018 and is projected to register a CAGR of 7.3% over the forecast period.

The increasing prevalence of cardiovascular disorders and growing older population are the key factors driving the automatic pill dispenser market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.

Various other factors such as the advancements in automatic pill dispenser, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on home care centers are also expected to propel the growth of the market.

However, the high cost of the system can hamper market growth over the forecast period.

Automatic Pill Dispenser Market Segmentation
The global automatic pill dispenser market is segmented based on type, end user, and region.
The global market for automatic pill dispenser, by type, is segmented into a centralized, automated dispensing system, and decentralized the automated dispensing system. The centralized, automated dispensing system is further classified into robotic automated dispensing systems, and carousels. Furthermore, the decentralized automated dispensing system is classified into a pharmacy-based automated dispensing system, ward-based automated dispensing system, and automated unit dose dispensing system.

Based on end user, the market is segmented into hospital pharmacy, retail pharmacy, and home healthcare.
The centralized, automated dispensing system segment is expected to witness the fastest growth over the forecast period due to increasing adoption in various hospitals as well as other healthcare facilities.

Automatic Pill Dispenser Market Key Players
Some of the key players in the global automatic pill dispenser market are Baxter International Inc, Becton, Dickinson and Company, Cerner Corporation, Capsa Healthcare, McKesson Corporation, Omnicell Inc., ScriptPro LLC, Swisslog Holdings AG, Yuyama Co.Ltd. Talyst, Inc., and others


Automatic Pill Dispenser Market Regional Analysis
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.

The automatic pill dispenser market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European automatic pill dispenser market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The automatic pill dispenser market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The automatic pill dispenser market in the Middle East & Africa has been segmented into the Middle East and Africa.

Meningococcal Vaccines Market Application, Technological Advancement, Key Players and Analysis Report Forecast To 2025

Meningococcal Vaccines Market overview 
Meningococcal is a bacterial infection that is caused by Neisseria meningitidis and is also known as meningococcal meningitis that targets the brain of the person. There have been many advances in the medical care sector, but these diseases pose a serious threat to the lives of the patients. Meningococcal meningitis can kill the host within a less time frame. As studied, one in ten patients of this disease die and 15% of the surviving patients suffer from serious brain complications.  

Meningococcal consists of different types of bacteria that cause this disease in humans. The most common types of bacteria include A, B, C, W, Y and X type. All these bacterias have been seen in Africa, where the condition of Meningococcal is quite critical and there is a continuous research and development for effective Meningococcal vaccines that will be available soon in the coming years.  

The global Meningococcal vaccines market report showcases the rising cases of this disease with the increasing demand for vaccines. According to the report, almost 10 to 15 in 100 people get affected with meningococcal disease. The escalation in positive result cases and the need for vaccines is boosting its demand in the global market. The Meningococcal vaccines market has risen upto USD 172 million in the year 2019 and the global supply is estimated to be 203 million doses for the forecast period till 2025.  

Meningococcal Vaccines Market Key Players
  • Baxter international
  • Pfizer Inc.
  • Sanofi S.A.
  • Novartis Pharmaceuticals Inc.
  • JN-International Medical Corporation
  • Serum Institute of India Ltd.
  • GlaxoSmithKline
  • BIO-MED
  • Others
Meningococcal Vaccines Market segmentation 
The global Meningococcal vaccines market is a booming market with a lot of investment and developments. Based on the treatment, the global product market can be divided into: 
  • Polysaccharide
  • Meningococcal Conjugate Vaccine
  • Subcapsular vaccine 
The Meningococcal A Conjugate Vaccine is mostly used in mass campaigns in affected regions of Africa. Since 2010, the demand for such vaccines has been uncertain, based on the national immunization programs that are being adopted based on the country’s effectiveness and readiness to tackle the disease. Moreover, the demand and supply for Subcap MenB vaccines is a desirable combination that will moderate the global product scenario. 
By the end-user, the global vaccine market can be split into: 
  • Research laboratories
  • Hospital and clinical
  • Academic institutes 
Meningococcal Vaccines Market Regional analysis 
As seen in a global scenario, China is expected to dominate the market and accounts for almost 35% of the global meningococcal vaccine demand. The Chinese vendors are focusing on meeting the demands for the domestic market and the polysaccharide products account for 84% of China’s demand. During 2016-2018, UNICEF introduced the meningococcal A conjugate vaccine in 26 countries and Ghana was the first country in Africa to receive this vaccination. Currently, the meningococcal vaccine has reached across different regions, in the most remote locations, and has increased in demand and supply in the global market. 


Meningococcal Vaccines Industry news 
The European Commission has approved RUXIENCE. It is a monoclonal antibody, developed by Pfizer Inc., for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, microscopic polyangiitis, and pemphigus vulgaris. This comprehensive package has been studied and evaluated with efficacy and safety. RUXIENCE is essential for treating certain cancers and other autoimmune conditions.

Friday, 24 April 2020

Patient Lift Slings Market – Revenue And Market Share Opportunities And Forecasts to 2025

Patient Lift Slings Market Analysis

Global Patient Lift Slings Market is expected to cross USD 6.07 Billion by 2025 at a CAGR of 12.4%.
Expanding pervasiveness of incessant issue requiring long haul patient consideration is foreseen to help the utilization of restorative lifting slings.

Geriatric populace shapes the objective populace for this market. This statistic is exceptionally inclined to age-related issue, which in specific cases causes stability in patients. In addition, the coming of old consideration focuses and long haul care focuses, restrictive for geriatric patients opens up roads for market players.

Home medicinal services is a monetary alternative over emergency clinics, where post-usable recuperation and long haul care can be benefited effectively through hospices or expert home social insurance administrations. Multiplication of these administrations gives business chances to market members to strategically pitch the items other than customary settings. The quickly developing demand for social insurance administrations is credited to the developing workforce in this field, which is relied upon to serve this market as a driver. Innovative technologies in therapeutic lifting slings rendered the patient lifting process proficient because of less wounds and disasters during the procedure. For example, use of water powered innovation in patient lifting builds the solace level for patients and lessens the additional endeavors required by the staff. Thus, mechanical progressions in this vertical are helping the market to develop quickly.

The administration alongside social insurance affiliations is endeavoring to bring down medicinal services costs. Home social insurance administrations are developing quickly as these administrations offer effective long haul patient consideration at a lower cost. Utilization of all patient taking care of hardware including patient lifting slings is advanced in these settings. Subsequently, the development of home social insurance is applying a significant effect on the market elements.

Patient Lift Slings Market Competitive Analysis:
The key players operating in the global patient lift slings market include Getinge Group (ArjoHuntleigh), Hill-Rom, Invacare Corporation, Joerns Healthcare LLC, Prism Medical, Argo Medical, Inc., DJO Global, -Spectra Care Group, and V.Guldmann A/S.

Patient Lift Slings Market Segmentation:
The patient lift slings market is segmented based on product, sling shape, sling materials, usage, end user, and region.
In terms of product, the global patient lift slings market is categorized into bariatric slings, seating slings, stand up sling, bathing & toileting slings, and other.
Based on the sling shape, the market is segmented into full body sling and U-shape.
Based on the sling material, the market is segmented into mesh, padded, nylon, polyester, and others.
Based on the usage, the market is segmented into reusable and disposable.
Based on the end user, the market is segmented into hospitals, home care settings, and others.


Patient Lift Slings Market Regional Analysis:
Based on the region, the market is segmented into Europe, the Americas, Asia Pacific, and the Middle East & Africa. Of these, the Europe are estimated hold strong position in the patient lift slings market owing to inferable from higher research costs and activities gives propelled gadgets and private-open organizations, and consequently held the most extreme offer in this vertical. What's more, pervasive constant illnesses and the presentation of strong repayment plans are the fundamental components overseeing the development of the vertical in this locale. However, Asia Pacific is foreseen to observe a quick development rate over the conjecture time frame. Expanding per capita salary and financial improvement and the nearness of high neglected needs of the enormous populace pool in this locale is relied upon to contribute toward huge development.

Dental Equipment Market 2020 Global Size, Share And Growth Analysis

Dental Equipment Market Analysis  
The dental equipment market is likely to touch USD 9,280.3 million at a 5.20% CAGR between 2016-2023, as per the latest Market Research Future (MRFR) report. Dental equipment is a tool used by dentists for identifying and treating dental conditions. Such tools are used for examining, manipulating, treating, restoring, and removing teeth and surrounding oral structures. It has wide application in dental laboratories, clinics, and hospitals. Hygiene maintenance devices, laboratory machines, systems and parts, dental lasers, dental radiology equipment, and others are the different types of dental equipment that are generally used by dental practitioners.  

Numerous factors are adding to the global dental equipment market. These factors, as per the MRFR report, include favorable government initiatives related to dental hygiene, demand for surgical, restorative, and preventive services for dental care, rising geriatric population, increase in medical tourism activities, increasing incidence of dental disorders, and demand for dental procedures. Additional factors adding market growth include poor oral hygiene, morbid diet, consumption of alcohol or tobacco, increase in dental practitioners and dental clinics, innovations in radiology and imaging, demand for cosmetic dentistry, and rising prevalence of periodontal diseases and dental caries. 

On the flip side, the high price of dental equipment may limit the global dental equipment market growth over the forecast period.  

Dental Equipment Market Segmentation 
The MRFR report provides an inclusive segmental analysis of the global dental equipment market based on end user, treatment, and product.  

By product, the global dental equipment market is segmented into hygiene maintenance devices, laboratory machines, systems and parts, dental lasers, dental radiology equipment, and others. Dental radiology equipment is again segmented into extra-oral and intra-oral. Dental lasers are again segmented into carbon dioxide lasers and diode lasers. System and parts are again segmented into cast machine, CAD/CAM, and others. Of these, systems and parts will lead the market during the forecast period.  

By treatment, the global dental equipment market is segmented into prosthodontic, periodontics, endodontics, and orthodontics. Of these, prosthodontic will dominate the market over the forecast period for increasing concern about appearance, which need prosthesis in dental cases and rising geriatric population.  

By end user, the global dental equipment market is segmented into dental laboratories, hospitals and clinics, and others. Of these, hospitals and clinics will have a major share in the market over the forecast period.  

Dental Equipment Market Regional Analysis  
By region, the global dental equipment market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market during the forecast period for the rising number of dental procedures, increasing number of dental clinics and dentists, rising geriatric population, and technological advances.  

The global dental equipment market in Europe is predicted to have a healthy growth over the forecast period for the increasing geriatric population, an increase in government expenditure on healthcare, and favorable reimbursement scenario.  

The global dental equipment market in the APAC region is predicted to grow at the fastest pace over the forecast period for the increase in medical tourism, the use of innovative technologies, less stringent regulations, and demand for dental procedures. Besides, the rising prevalence of oral cancer is also adding market growth.  

The global dental equipment market in the MEA is predicted to have steady growth over the forecast period for the growing demand for dental procedures. 


Dental Equipment Market Key Players 
Notable players profiled in the global dental equipment market report include Danaher Corporation, Carestream Health Inc., GC Corporation, Bien-Air Medical Technologies, 3M, Midmark Corporation, A-dec Inc., KaVo Dental, Patterson Companies Inc., Biolase Inc, Dentsply International, Inc., Henry Schein, Inc., and Sirona Dental Systems.